A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Condition:   ShinglesInterventions:   Drug: FV-100;   Drug: valacyclovirSponsor:   ContraVir Pharmaceuticals, Inc.Not yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2015 Category: Research Source Type: clinical trials

Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Condition:   Congenital Cytomegalovirus InfectionInterventions:   Drug: Valacyclovir;   Drug: PlaceboSponsor:   Rabin Medical CenterNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2015 Category: Research Source Type: clinical trials

A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Condition:   SchizophreniaInterventions:   Drug: Valacyclovir HCI 500 mg tablets;   Drug: placeboSponsors:   Indiana University;   Stanley Medical Research Institute;   Sheppard Pratt Health System;   University of Maryland;   Centers for Behavioral Health, LLC;   Laureate Institute for Brain Research, Inc.;   University of Kansas Medical Center Research Institute, Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2013 Category: Research Source Type: clinical trials

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Conditions:   Transplantation Infection;   Epstein-Barr Virus Infections;   Cytomegalovirus InfectionsInterventions:   Drug: Valacyclovir;   Drug: ValganciclovirSponsor:   University of Minnesota - Clinical and Translational Science InstituteRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2013 Category: Research Source Type: clinical trials